Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 44.91

Sichuan Kelun Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 10.0% to reach an intraday low of CNY 44.91. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Despite today's downturn, Sichuan Kelun has shown resilience over the longer term. Over the past month, the stock has gained 26.08%, outperforming the Shanghai Composite, which declined by 8.37%. Year-to-date, the company has achieved a remarkable 53.02% increase, while the index has faced a loss of 5.16%. However, the company has faced challenges, reporting negative results for the last six consecutive quarters. Key financial metrics indicate a decline in net profit, which has decreased by 32.93% over the past nine months. Additionally, the operating cash flow is at its lowest point, recorded at CNY 2,608.1 million, and the return on capital employed stands at 6.58%. With a market capitalization of CNY 39,696 million, Sichuan Kelun remains a notable player in the pharmaceuticals and biotechnology sector.